Haptoglobin and risk of myocardial infarction, stroke, and congestive heart failure in 342,125 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)

References

• Ross P. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999; 340: 115–26
   PubMed Web of Science ®Google Scholar
• Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002; 105: 1135–43
   PubMed Web of Science ®Google Scholar
• Lind P, Engström G, Stavenow L, Janzon L, Lindgärde F, Hedblad B. Risk of myocardial infarction and stroke in smokers is related to plasma levels of inflammation-sensitive proteins. Arterioscler Thromb Vasc Biol. 2004; 24: 577–82
   PubMed Web of Science ®Google Scholar
• Engström G, Lind P, Hedblad B, Stavenow L, Janzon L, Lindgärde F. Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men. Circulation. 2002; 105: 2632–7
   PubMed Web of Science ®Google Scholar
• Engström G, Stavenow L, Hedblad B, Lind P, Tydén P, Janzon L, et al. Inflammation-sensitive plasma proteins and incidence of myocardial infarction in men with low cardiovascular risk. Arterioscler Thromb Vasc Biol. 2003; 23: 2247–51
   PubMed Web of Science ®Google Scholar
• Rifai N, Ridker PM. High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem. 2001; 47: 403–11
   PubMed Web of Science ®Google Scholar
• Ridker PM. C-reactive protein: eighty years from discovery to emergence as a major risk marker for cardiovascular disease. Clin Chem. 2009; 55: 209–15
   PubMed Web of Science ®Google Scholar
• Quaye IK. Haptoglobin, inflammation and disease. Review. Trans R Soc Trop Med Hyg. 2008; 102: 735–42
   PubMed Web of Science ®Google Scholar
• Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein A-1, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet. 2001; 358: 2026–33
   PubMed Web of Science ®Google Scholar
• Holme I, Aastveit AH, Jungner I, Walldius G. Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow-up periods in the Apolipoprotein MOrtality RISk study (AMORIS). J Int Med. 2008; 264: 30–8
   PubMed Web of Science ®Google Scholar
• Walldius G, Aastveit AH, Jungner I. Stroke mortality and the apoB/apoA-1 ratio: results of the AMORIS prospective study. J Int Med. 2006; 259: 259–66
   PubMed Web of Science ®Google Scholar
• Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G. Relationships between lipoprotein components and risk of ischaemic and haemorrhagic stroke in the Apolipoprotein MOrtality RISk study (AMORIS). J Int Med. 2008; 265: 275–87
   PubMed Web of Science ®Google Scholar
• Walldius G, Jungner I, Kolar W, Holme I, Steiner E. High cholesterol and triglyceride values in Swedish males and females: increased risk of fatal myocardial infarction. First report from the AMORIS (Apolipoprotein related MOrtality RISk) study. Blood Pressure. 1992; 1(Suppl 4)35–42
   PubMedGoogle Scholar
• Medin J, Nordlund A, Ekberg K. Increasing stroke incidence in Sweden between 1989 and 2000 among persons aged 30 to 65 years: evidence from the Swedish Hospital Discharge Register. Stroke. 2004; 35: 1047–51
   PubMed Web of Science ®Google Scholar
• Lindblad U, Råstam L, Ranstam J, Peterson M. Validity of register data on acute myocardial infarction and acute stroke: the Skaraborg Hypertension Project. Scand J Soc Med. 1993; 21: 3–9
   PubMedGoogle Scholar
• Stegmayr B, Asplund K. Measuring stroke in the population: quality of routine statistics in comparison with a population-based stroke registry. Neuroepidemiology. 1992; 11: 204–13
   PubMed Web of Science ®Google Scholar
• Stegmayr, B, Glader, E-L. Five years with Riks-Stroke. The Swedish national register for quality assessment of acute stroke care. Available at: http://www.riks-stroke.org (assessed on 27 July 2009).
   Google Scholar
• Glader EL, Stegmayr B, Norrving B, Terént A, Hulter-Åsberg K, Wester PO, et al. Riks-Stroke Collaboration. Sex differences in management and outcome after stroke: a Swedish national perspective. Stroke. 2003; 34: 1970–5
   PubMed Web of Science ®Google Scholar
• Appelros P, Nydevik I, Seiger A, Terént A. High incidence rates of stroke in Örebro, Sweden: Further support for regional incidence differences within Scandinavia. Cerebrovasc Dis. 2002; 14: 161–8
   PubMed Web of Science ®Google Scholar
• Hammar N, Alfredsson L, Rosén M, Spetz C-L, Kahan T, Ysberg A-S. A national record linkage to study acute myocardial infarction incidence and case fatality in Sweden. Int J Epidemiol. 2001; 30(Suppl 1)S30–4
   Google Scholar
• Kümler T, Gislason GH, Kirk V, Bay M, Nielsen OW, Køber L, et al. Accuracy of a heart failure diagnosis in administrative registers. Eur J Heart Fail. 2008; 10: 658–60
   PubMed Web of Science ®Google Scholar
• Ingelsson E, Ärnlöw J, Sundström J, Lind L. The validity of a diagnosis of heart failure in a hospital discharge register. Eur J Heart Fail. 2005; 7: 787–91
   PubMed Web of Science ®Google Scholar
• Jungner I, Walldius G, Holme I, Kolar W, Steiner E. Apolipoprotein B and A-1 in relation to serum cholesterol and triglycerides in 43 000 Swedish males and females. Int J Clin Lab Res. 1992; 21: 247–55
   PubMedGoogle Scholar
• Jungner I, Marcovina SM, Walldius G, Holme I, Kolar W, Steiner E. Apolipoprotein B and A-1 values in 147 576 Swedish males and females, standardized according to the World Health Organization–-International Federation of Clinical Chemistry First International Reference Materials. Clin Chem. 1998; 44: 1641–49
   PubMed Web of Science ®Google Scholar
• Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology. 1992; 3: 452–6
   PubMed Web of Science ®Google Scholar
• Lundberg M, Fredlund P, Hallquist J, Dederichsen F. A SAS program calculating three measures of interaction with confidence intervals. Epidemiology. 1996; 7: 655–6
   PubMed Web of Science ®Google Scholar
• Rothmann KJ. The estimation of synergism and antagonism. Am J Epidemiol. 1976; 103: 506–11
   PubMed Web of Science ®Google Scholar
• De Bacquer D, De Backer G, Langlois M, Delanghe J, Kesteloot H, Kornitzer M. Haptoglobin polymorphism as a risk factor for coronary heart disease mortality. Atherosclerosis. 2001; 157: 161–6
   PubMed Web of Science ®Google Scholar
• Engström G, Hedblad B, Janzon L, Lindgärde F. Long-term change in cholesterol in relation to inflammation-sensitive plasma proteins: A longitudinal study. Ann Epidemiol. 2007; 17: 57–63
   PubMed Web of Science ®Google Scholar
• Levy AP. Modification of HDL structure and function in individuals with diabetes and the haptoglobin 2-2 genotype. Clin Lipidology. 2009; 4: 5–8
   Web of Science ®Google Scholar
• Walldius G, Jungner I. Apolipoprotein B and apolipoprotein A-1: risk indicators of coronary heart disease and targets for lipid-modifying therapy. J Int Med. 2004; 255: 188–205
   PubMed Web of Science ®Google Scholar
• Salvatore A, Cigliano L, Bucci EM, Corpillo D, Velasco S, Carlucci A, et al. Haptoglobin binding to apolipoprotein A-1 prevents damage from hydroxyl radicals on its stimulatory activity of the enzyme lecithin-cholesterol acyl-transferase. Biochemistry. 2007; 46: 11158–68
   PubMed Web of Science ®Google Scholar
• Orion Diagnostics, Helsinki, Finland. Rapid immunochemical determination of C-Reactive Protein using clinical chemistry analyzers (January 1982), www.oriondiagnostica.com (assessed on 27 July 2009).
   Google Scholar
• Ridker PM, Rifai N, Cook NR, Bradwin G, Buring JE. Non-HDL cholesterol, apolipoproteins A-1 and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA. 2005; 294: 326–33
   PubMed Web of Science ®Google Scholar
• Sierra-Johnson J, Fisher RM, Romero-Corral A, Somers VK, Lopez-Jimenez F, Öhrvik J, et al. Concentration of apolipoprotein B is comparable with the apolipoprotein B/ apolipoprotein A-1 ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population. Eur Heart J. 2009; 30: 710–7
   PubMed Web of Science ®Google Scholar
• Holzmann, MJ, Jungner, I, Walldius, G, Ivert, T, Nordqvist, T, Östergren, J, et al,. Apolipoproteins B and A-I, standard lipid measures and incidence of myocardial infarction in men and women, with or without chronic kidney disease. Study IV in Thesis for doctorial degree (Ph.D.), In: M. Holzmann. Renal insufficiency, mortality and myocardial infarction. Karolinska Institutet, Stockholm; 2008.
   Google Scholar